Showing results (331-340 of 356) with videos related to

Sort By:
Pageof 36
Neuro-Oncology|January 14, 2023
Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trialJohn H Sampson, Achal Singh Achrol, Manish K Aghi, et al.
Expert Opinion on Investigational Drugs|December 10, 2016
RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trialsBryan Oronsky, Ramasamy Paulmurugan, Kira Foygel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2009
Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathyPaul G Richardson, Wanling Xie, Constantine Mitsiades, et al.
Neuro-Oncology|February 24, 2016
A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapyEudocia Q Lee, Alona Muzikansky, Jan Drappatz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2019
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with GlioblastomaPatrick Y Wen, David A Reardon, Terri S Armstrong, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2026
A pooled analysis of phase 2 clinical trials in advanced chordomaGregory M Cote, Corrine F Elliott, Astrid Lipplaa, et al.
Neuro-Oncology|March 19, 2009
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.
Neurology|September 4, 2024
Mesenchymal Stromal Cell Implants for Chronic Motor Deficits After Traumatic Brain Injury: Post Hoc Analysis of a Randomized TrialDavid O Okonkwo, Peter McAllister, Achal S Achrol, et al.
Journal of Alzheimer'S Disease : JAD|November 14, 2022
Differentiation of Subjective Cognitive Decline, Mild Cognitive Impairment, and Dementia Using qEEG/ERP-Based Cognitive Testing and Volumetric MRI in an Outpatient Specialty Memory ClinicAarthi S Ganapathi, Ryan M Glatt, Tess H Bookheimer, et al.
Neuro-Oncology|May 16, 2018
Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FCTimothy F Cloughesy, Joseph Landolfi, Michael A Vogelbaum, et al.
Pageof 36